Novel functionalized 5-(phenoxymethyl)-1,3-dioxane analogs exhibitng cytochrome p450 inhibition

作者: Magid A Abou-Gharbia , Rajashekar Reddy Nimmareddy , Ramreddy Bobbala , Pravin Iyer , Benjamin Eric Blass

DOI:

关键词:

摘要: Pharmaceutical compositions described in this document comprise 5-(phenoxymethyl)-1,3-dioxane analogs having a disease-modifying action the treatment of diseases associated with production cortisol that include metabolic syndrome, obesity, headache, depression, hypertension, diabetes mellitus, Cushing's Syndrome, pseudo-Cushing cognitive impairment, dementia, heart failure, renal psoriasis, glaucoma, cardiovascular disease, cancer, stroke, incidentalomas, or any involving overproduction cortisol.

参考文章(12)
Joseph H. Mostmans, Jan Heeres, Leo J. J. Backx, Novel 1-(1,3-dioxolan-2-ylmethyl)-1H-imidazoles ,(1977)
Mainkar S. Prathama, Peteris Alberts, Alexandra Santana Sorensen, Jean-Philippe Meyer, Melya Hughes Crameri, Substituted 1,3-dioxanes useful as ppar modulators ,(2008)
Ulrike E. Hille, Christina Zimmer, Carsten A. Vock, Rolf W. Hartmann, Selective cyp11b1 inhibitors for the treatment of cortisol dependent diseases ACS Medicinal Chemistry Letters. ,vol. 2, pp. 2- 6 ,(2011) , 10.1021/ML100071J
Qingzhong Hu, Carsten Jagusch, Ulrike E. Hille, Jörg Haupenthal, Rolf W. Hartmann, Replacement of imidazolyl by pyridyl in biphenylmethylenes results in selective CYP17 and dual CYP17/CYP11B1 inhibitors for the treatment of prostate cancer. Journal of Medicinal Chemistry. ,vol. 53, pp. 5749- 5758 ,(2010) , 10.1021/JM100317B
Susanne Veronica Hylén, Asa Helen Fyge, Barbro Helena Ljusberg, Pharmaceutical formulations comprising ketoconazole ,(2002)
Timothy Andrew Stewart, Ketoconazole enantiomer in humans ,(2007)
Tao Ye, Bing Wang, Daniel Chu, Cyp11b, cyp17, and/or cyp21 inhibitors ,(2011)